Department of Early Phase Clinical Trials, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Department of Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital of Essen, Essen; Department of Translational Skin Cancer Research, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
ESMO Open. 2024 May;9(5):102977. doi: 10.1016/j.esmoop.2024.102977. Epub 2024 Apr 30.
• This ESMO Clinical Practice Guideline provides key recommendations for managing Merkel-cell carcinoma (MCC). • Recommendations are based on available scientific data and the multidisciplinary group of experts’ collective opinion. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Algorithms for the management of locoregional and inoperable/metastatic disease are provided. • A multidisciplinary team with a high level of expertise in MCC should diagnose and make decisions about therapy.
• 本 ESMO 临床实践指南提供了管理 Merkel 细胞癌 (MCC) 的关键建议。 • 建议基于现有科学数据和多学科专家组的集体意见。 • 该指南涵盖了临床和病理诊断、分期和风险评估、治疗和随访。 • 提供了局部区域和不可手术/转移性疾病管理的算法。 • 应由具有 MCC 专业知识的多学科团队进行诊断和制定治疗决策。